EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV‑2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals

Sizhu Amelia Chen, Elena Arutyunova, Jimmy Lu, Muhammad Bashir Khan, Wioletta Rut iD, Mikolaj Zmudzinski iD, Shima Shahbaz, Jegan Iyyathurai, Eman W Moussa, Zoe Turner iD, Bing Bai, Tess Lamer iD und 7 weitere

ACS Central Science · 26.04.2023 · 9 (4) · 696-708

DOI: 10.1021/acscentsci.3c00054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 21.03.2023. Verfasst von Sizhu Amelia Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Government of Alberta, , Canadian Institutes of Health Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main protease of SARS-CoV-2 (Mpro) is the most promising drug target against coronaviruses due to its essential role in virus replication. With newly emerging variants there is a concern that mutations in Mpro may alter the structural and functional properties of protease and subsequently the potency of existing and potential antivirals. We explored the effect of 31 mutations belonging to 5 variants of concern (VOCs) on catalytic parameters and substrate specificity, which revealed changes in substrate binding and the rate of cleavage of a viral peptide. Crystal structures of 11 Mpro mutants provided structural insight into their altered functionality. Additionally, we show Mpro mutations influence proteolysis of an immunomodulatory host protein Galectin-8 (Gal-8) and a subsequent significant decrease in cytokine secretion, providing evidence for alterations in the escape of host-antiviral mechanisms. Accordingly, mutations associated with the Gamma VOC and highly virulent Delta VOC resulted in a significant increase in Gal-8 cleavage. Importantly, IC50s of nirmatrelvir (Pfizer) and our irreversible inhibitor AVI-8053 demonstrated no changes in potency for both drugs for all mutants, suggesting Mpro will remain a high-priority antiviral drug candidate as SARS-CoV-2 evolves.

Autor:innen und Institutionen

  • Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.
  • Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
  • Department of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wroclaw, 50-370, Poland.
  • Department of Dentistry & Dental Hygiene, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
  • Li Ka Shing Applied Virology Institute, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
  • Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.

ORCID-Profile: Wioletta Rut, Mikolaj Zmudzinski, Zoe Turner, Tess Lamer, James A Nieman, John C Vederas, Olivier Julien, Marcin Drag, Shokrollah Elahi, Howard S Young, M Joanne Lemieux

Förderung

  • NIGMS NIH HHS
  • Government of Alberta
  • , Canadian Institutes of Health Research
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada
  • Canada Foundation for Innovation
  • Narodowe Centrum Nauki
  • Alberta Innovates

Zitieren

APA

Chen, S. A., Arutyunova, E., Lu, J., Khan, M. B., Rut, W., Zmudzinski, M., Shahbaz, S., Iyyathurai, J., Moussa, E. W., Turner, Z., Bai, B., Lamer, T., Nieman, J. A., Vederas, J. C., Julien, O., Drag, M., Elahi, S., Young, H. S., & Lemieux, M. J. (2023). SARS-CoV‑2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. ACS Central Science, 9(4), 696-708. https://doi.org/10.1021/acscentsci.3c00054

Vancouver

Chen SA, Arutyunova E, Lu J, Khan MB, Rut W, Zmudzinski M, et al. SARS-CoV‑2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. ACS Central Science. 2023;9(4):696-708. doi:10.1021/acscentsci.3c00054

BibTeX
@article{Chen2023,
  author = {Chen, Sizhu Amelia and Arutyunova, Elena and Lu, Jimmy and Khan, Muhammad Bashir and Rut, Wioletta and Zmudzinski, Mikolaj and Shahbaz, Shima and Iyyathurai, Jegan and Moussa, Eman W and Turner, Zoe and Bai, Bing and Lamer, Tess and Nieman, James A and Vederas, John C and Julien, Olivier and Drag, Marcin and Elahi, Shokrollah and Young, Howard S and Lemieux, M Joanne},
  title = {SARS-CoV‑2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals},
  journal = {ACS Central Science},
  year = {2023},
  volume = {9},
  number = {4},
  pages = {696--708},
  doi = {10.1021/acscentsci.3c00054}
}
Kostenlos starten →